Related Experiment Videos
Practice patterns in haemophilia A therapy -- global progress towards optimal care
S Geraghty1, T Dunkley, C Harrington
1Mountain States Regional Haemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, CO, USA. sue.geraghty@uchsc.edu
Summary
A global survey reveals under half of severe hemophilia A patients receive prophylaxis, with infrequent bleeds and cost cited as barriers. Further research is needed for optimal treatment protocols.
Area of Science:
- Hematology
- Global Health
- Patient Care Management
Background:
- Hemophilia A is a significant bleeding disorder requiring specialized management.
- Global practice patterns for hemophilia A treatment are not well-documented.
- Understanding current management strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To conduct a global survey of practice patterns in hemophilia A management.
- To identify current treatment approaches and barriers to optimal care.
- To inform future research for improved hemophilia A treatment protocols.
Main Methods:
- A worldwide survey of 147 hemophilia treatment centers.
- Data collected on 16,115 patients with hemophilia A.
- Analysis of patient demographics, treatment modalities, and reasons for treatment choices.
Main Results:
- 38% of patients were under 18 years old; 47% had mild/moderate, 48% severe (no inhibitor), and 5% inhibitor hemophilia A.
- Less than half of severe hemophilia A patients received prophylaxis (37%); 54% received on-demand treatment.
- Barriers to prophylaxis included infrequent bleeds (80%), venous access issues (60%), and cost (45%).
Conclusions:
- Significant variation exists in prophylaxis rates for severe hemophilia A globally.
- Barriers to prophylactic treatment require targeted interventions.
- Continued worldwide research is essential to optimize hemophilia A management and improve patient outcomes.